ShiLai™Healthcare

---

ShiLai™Healthcare is a global leading biopharmaceutical company founded in 2013, specializing in the research, development, production, and distribution of high-quality biopharmaceuticals. The company is committed to providing innovative medications and medical devices for the global market, particularly in the treatment of diabetes, obesity, and other metabolic diseases. As a pioneer in the industry, ShiLai™Healthcare offers a range of products, including pre-filled injection pens and lyophilized powder systems, tailored to meet the needs of various markets and patients  

Founded in 2013, ShiLai™Healthcare rapidly became a key player in the global biopharmaceutical field. With advanced production facilities and exceptional research capabilities, the company focuses on the development of high-quality and innovative drugs, promoting its products worldwide. The company is dedicated to scientific innovation and has established partnerships with medical institutions and pharmaceutical companies around the globe to provide advanced treatment solutions for patients worldwide.  

ShiLai™Healthcare offers a wide range of biopharmaceutical products, primarily including pre-filled injection pens, lyophilized powders, and solvent mixing systems. The company is particularly known for its Retatrutide Pen, used in the treatment of diabetes and obesity, which has become a primary choice for suppliers in many countries worldwide. Other notable products include:

• Survodutide and Survodutide Pen – a pre-filled pen for metabolic and weight management therapies.
   
• Tirzepatide Pen – a dual GLP-1 and GIP receptor agonist pen for diabetes and obesity treatment.
   
• NAD⁺ 1000mg Pen – a pre-filled research pen for cellular health and metabolic support.
   
• GHK-Cu 100mg Pen – a pre-filled pen containing copper peptide for tissue repair and skin health.
   
• Klow Blend 70mg – a combination blend containing GHK-Cu 50mg, BPC-157 10mg, and TB-500 10mg in a pre-filled pen.
   

In addition to standard products, ShiLai™Healthcare provides customized services for distributors, including tailored packaging, labeling, and drug dosages according to the specific needs of different markets.

ShiLai™Healthcare provides customized solutions for distributors, including packaging design, labeling, and dosage adjustments. This enables the company to deliver highly personalized products that meet the regulatory requirements, patient needs, and market trends of different countries and regions. Through this service, ShiLai™Healthcare ensures its global partners can effectively compete in their respective markets.  

ShiLai™Healthcare actively invests in research and development, striving to create more innovative treatment solutions. The company employs cutting-edge technology and has established multiple modern production facilities to ensure the quality and efficiency of its products. By collaborating with leading global research institutions, ShiLai™Healthcare continues to drive industry innovation, developing new drugs and therapies to address growing global health challenges.  

ShiLai™Healthcare has established an extensive business network across multiple countries and regions worldwide. The company ensures that it can meet global demand through efficient production, logistics, and sales channels. Currently, ShiLai™Healthcare is one of the key suppliers in several countries, particularly in the fields of diabetes, obesity, and related metabolic diseases, with its products gaining widespread recognition in international markets.